19.09.2007 17:24:00
|
Mentor Corporation Announces Shareholders' Meeting Results and Adjournment; Declares Quarterly Cash Dividend
Mentor Corporation (NYSE:MNT) announced today that at its annual meeting
of shareholders convened on September 17, 2007 Joshua Levine, Michael
Emmons, Walter Faster, Margaret Jordan, Katherine Napier, Ronald Rossi
and Joseph Whitters were all re-elected to the Mentor Board of Directors
and Burt Rosen was elected to the Board of Directors. All directors hold
office until the next annual meeting of shareholders or until their
successors are duly elected and qualified. In addition the shareholders
ratified the selection of Ernst & Young LLP as Mentor’s
independent registered public accounting firm.
The meeting was also called for the purpose of approving an amendment to
Mentor’s Restated Articles of Incorporation to
increase the total number of shares of authorized capital stock and to
provide for the issuance of preferred stock in one or more series.
Approval of this proposal requires the approval of a majority of the
voting power of the outstanding shares present and entitled to vote on
this matter. Therefore, abstentions have the same effect as votes
against such proposals. Broker non-votes as to this proposal are not
deemed shares entitled to vote on the proposal, and will not be counted
as votes for or against the proposal or included in the calculation of
the number of votes necessary for approval of the proposal. As of the
time of the meeting, approximately 49% of the votes cast had been cast
in favor of the proposal, with a substantial number of broker non-votes
and other shares not represented in the voting. After considering the
importance of the matter, the number of votes not cast and the fact that
shareholders represented at the meeting were so closely divided on the
proposal, shareholders present at the meeting approved a motion
presented by management to adjourn and reconvene the meeting to allow
additional time to solicit proxies from those shareholders who had not
voted on the proposal.
Mentor’s annual meeting is adjourned to
October 1, 2007, at 10:00 a.m. local time, at Mentor’s
main office, located at 201 Mentor Drive, Santa Barbara, CA 93111.
Shareholders who have not voted on the proposal to approve the amendment
of Mentor’s Restated Articles of Incorporation
are encouraged to do so promptly. For shareholders who have voted on
this proposal, no additional action is required. Proxies may be
submitted or revoked any time prior to the adjourned meeting on October
1, 2007. To request an additional proxy card, please contact Joseph A.
Newcomb or Loren L. McFarland at (805) 879-6000.
Shareholders and other investors are urged to read the proxy statement,
which contains important information that should be read carefully
before any decision is made with respect to this proposal.
The Company also announced that its Board of Directors has declared a
quarterly cash dividend of $0.20 per share for the Company’s
second quarter, fiscal year 2008, payable on October 18, 2007 to
shareholders of record as of September 27, 2007.
About Mentor Corporation
Founded in 1969, Mentor Corporation is a leading supplier of medical
products for the global aesthetic market. The Company develops,
manufactures and markets innovative, science-based products for surgical
and non-surgical medical procedures that allow patients to retain a more
youthful appearance and improve personal well-being. The Company’s
website is www.mentorcorp.com.
Safe Harbor Statement
All statements included or incorporated by reference in this release,
other than statements or characterizations of historical fact, are
forward-looking statements. These forward-looking statements are based
on our current expectations, estimates and projections about our
industry, management's beliefs and certain assumptions made by us. These
forward-looking statements speak only as of the date hereof and are
based upon the information available to us at this time. Such
information is subject to change, and we will not necessarily inform you
of such changes. These statements are not guarantees of future results
and are subject to risks, uncertainties and assumptions that are
difficult to predict. Therefore, our actual results could differ
materially and adversely from those expressed in any forward-looking
statement as a result of various factors.
The Securities and Exchange Commission filings of Mentor, including,
without limitation, its Annual Report on Form 10-K, subsequent quarterly
report on Form 10-Q, and recent Current Reports on Form 8-K, discuss
important risk factors that could contribute to such differences or
otherwise affect its business, results of operations and financial
condition. Mentor undertakes no obligation to revise or update publicly
any forward-looking statement for any reason.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
JETZT DEVISEN-CFDS MIT BIS ZU HEBEL 30 HANDELN
Handeln Sie Devisen-CFDs mit kleinen Spreads. Mit nur 100 € können Sie mit der Wirkung von 3.000 Euro Kapital handeln.
82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren.
Nachrichten zu Johnson & Johnsonmehr Nachrichten
29.11.24 |
Aufschläge in New York: nachmittags Pluszeichen im Dow Jones (finanzen.at) | |
27.11.24 |
Mittwochshandel in New York: Dow Jones mittags schwächer (finanzen.at) | |
27.11.24 |
Dow Jones 30 Industrial-Titel Johnson Johnson-Aktie: So viel hätte eine Investition in Johnson Johnson von vor 3 Jahren gekostet (finanzen.at) | |
26.11.24 |
Dow Jones aktuell: Dow Jones letztendlich mit Gewinnen (finanzen.at) | |
26.11.24 |
Zuversicht in New York: Dow Jones am Dienstagnachmittag mit Gewinnen (finanzen.at) | |
26.11.24 |
Verluste in New York: Dow Jones verbucht am Mittag Abschläge (finanzen.at) | |
22.11.24 |
Dow Jones-Handel aktuell: Dow Jones zum Ende des Freitagshandels mit Kursplus (finanzen.at) | |
22.11.24 |
Starker Wochentag in New York: Dow Jones verbucht Zuschläge (finanzen.at) |
Analysen zu Johnson & Johnsonmehr Analysen
Aktien in diesem Artikel
Johnson & Johnson | 146,90 | -0,31% |
Indizes in diesem Artikel
S&P 600 SmallCap | 935,46 | -0,94% |